Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 2.140
-0.020 (-0.93%)
Jul 24, 2026, 5:03 PM CET
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 26.2 million as of July 24, 2026. Its market cap has increased by 11.36% in one year.
Market Cap
26.20M
Enterprise Value
41.63M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.14
ChartMarket Cap Chart
Since December 11, 2018, Pure Biologics's market cap has decreased from 26.85M to 26.20M, a decrease of -2.40%. That is a compound annual growth rate of -0.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 26.20M | -9.88% |
| Dec 30, 2025 | 29.08M | -54.90% |
| Dec 30, 2024 | 64.47M | 53.27% |
| Dec 29, 2023 | 42.06M | -18.86% |
| Dec 30, 2022 | 51.84M | -70.44% |
| Dec 30, 2021 | 175.36M | -4.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioceltix | 522.80M |
| Captor Therapeutics Spolka Akcyjna | 470.15M |
| Ryvu Therapeutics | 349.58M |
| BIOTON | 330.15M |
| Synthaverse | 210.64M |
| Poltreg | 136.08M |
| Molecure | 121.35M |
| Mabion | 118.47M |